Differential inhibition of various deoxyribonucleic acid polymerases by Evans blue and aurintricarboxylic acid
- 1 October 1988
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 177 (1) , 91-96
- https://doi.org/10.1111/j.1432-1033.1988.tb14348.x
Abstract
The inhibitory effects of two anionic compounds, Evans blue and aurintricarboxylic acid (ATA), on various kinds of polynucleotide-synthesizing enzymes were examined. Under the assay conditions, optimized for each enzyme species, both these compounds strongly inhibited the activities of the purified human DNA polymerases .alpha., .beta., .gamma., and DNA primase as well as those of DNA polymerase I and RNA polymerase from Escherichia coli and Rauscher leukemia virus reverse transcriptase. ATA was particularly effective in inhibiting retroviral reverse transcriptase and cellular DNA polymerase .alpha.. Evans blue, which is a structural analogue of suramin, exerted its inhibitory action largely by competing with the template primer for the same binding site of the enzyme. On the other hand, ATA inhibited most, if not all, of these enzyme activities noncompetitively with respect to either the template, primers or nucleoside 5''-triphosphate substrates. The inhibition constants for ATA were, in general, smaller than those for Evans blue.This publication has 18 references indexed in Scilit:
- Differential inhibition of various deoxyribonucleic and ribonucleic acid polymerases by suraminEuropean Journal of Biochemistry, 1988
- Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS)Journal of Medicinal Chemistry, 1986
- Aurintricarboxylic acid and evans blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virusBiochemical and Biophysical Research Communications, 1986
- Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T‐cell lymphotropic virus (HTLV‐III)/lymphadenopathy‐associated virus (LAV)International Journal of Cancer, 1986
- EFFECTS OF SURAMIN ON HTLV-III/LAV INFECTION PRESENTING AS KAPOSI'S SARCOMA OR AIDS-RELATED COMPLEX: CLINICAL PHARMACOLOGY AND SUPPRESSION OF VIRUS REPLICATION IN VIVOThe Lancet, 1985
- ANTIMONIOTUNGSTATE (HPA 23) TREATMENT OF THREE PATIENTS WITH AIDS AND ONE WITH PRODROMEThe Lancet, 1985
- Suramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-IIIScience, 1984
- Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor virusesCancer Letters, 1979
- Studies on DNA α-polymerase of mouse myeloma: partial purification and comparison of three molecular forms of the enzymeBiochemistry, 1976
- Inhibition of RNA-dependent DNA polymerase of murine oncornaviruses by ammonium-5-tungsto-2-antimoniateBiochemical and Biophysical Research Communications, 1975